MATT HALL: Open Payments
NPI 1699792176 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 68 payments from 14 companies in 2025. Trend: 2023 $1,913 · 2024 $1,829 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $201 |
| PFIZER INC. | 8 | $184 |
| AstraZeneca Pharmaceuticals LP | 10 | $181 |
| ABBVIE INC. | 12 | $165 |
| Lilly USA, LLC | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Exact Sciences Corporation | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $42 |
Products named: Wegovy, AIRSUPRA, ELIQUIS, JARDIANCE, Ozempic, MOUNJARO, Auvelity, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
